CN105412563A - 冬虫夏草中药酒 - Google Patents
冬虫夏草中药酒 Download PDFInfo
- Publication number
- CN105412563A CN105412563A CN201510909666.3A CN201510909666A CN105412563A CN 105412563 A CN105412563 A CN 105412563A CN 201510909666 A CN201510909666 A CN 201510909666A CN 105412563 A CN105412563 A CN 105412563A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- lung
- cordyceps
- wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title abstract description 16
- 241001248610 Ophiocordyceps sinensis Species 0.000 title abstract 4
- 241000756943 Codonopsis Species 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims description 14
- 241000190633 Cordyceps Species 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 210000004072 lung Anatomy 0.000 abstract description 33
- 206010011224 Cough Diseases 0.000 abstract description 28
- 201000010099 disease Diseases 0.000 abstract description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 23
- 230000007812 deficiency Effects 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 230000035922 thirst Effects 0.000 abstract description 10
- 210000001124 body fluid Anatomy 0.000 abstract description 8
- 239000010839 body fluid Substances 0.000 abstract description 8
- 208000017574 dry cough Diseases 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 244000062793 Sorghum vulgare Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- 235000019713 millet Nutrition 0.000 abstract 1
- 235000009508 confectionery Nutrition 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000015220 Febrile disease Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000002918 waste heat Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000722910 Burkholderia mallei Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical class O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种冬虫夏草中药酒,其原料药材分别是:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份、黄酒3000份;本发明所述冬虫夏草中药酒,本产品具有润肺补肾、活血滋补、益气滋阴、生津止渴的功效,用于肺虚干咳、虚劳咳嗽等症疗效确切。
Description
技术领域
本发明涉及中药酒领域,具体涉及由中药原料与酒配伍制成的养生中药酒。本产品具有润肺补肾、活血滋补、益气滋阴、生津止渴的功效,用于肺虚干咳、虚劳咳嗽等症疗效确切。
背景技术
肺结核是结核杆菌通过呼吸道感染侵入肺部引起炎症反应。结核杆菌通常寄居在呼吸性细支气管或肺泡并通过吸入带菌微滴由一个人传染给另一个人;它也可以通过饮用已被污染而却未进行巴斯德法消毒的牛奶而由胃肠道进入人体,偶尔还可通过皮肤损伤进入。其基本病理变化有渗出、增殖和变质三个方面。当人体免疫力增强和在抗菌药物治疗下病灶可逐渐愈合.属中医的“肺痨”范畴。中医学认为本病病因不外乎内因与外因两个方面,外因是感染,内因是气血两虚,阴精耗损。因为正气先伤,体虚不复,则痨虫乘虚侵入,痨虫蚀肺,肺阴不足,热伤肺络则见干咳、咯血、咽燥等症。肺虚不能输布津液,肾失资生之源,则病及于肾,肾阴不足,虚火扰动,则见骨蒸潮热,男子梦遗失精,女子闭经,甚则真阴不足,心肝火旺,上走於肺,愈至消灼肺阴,则见盗汗不寐,烦躁善怒,胸胁疼痛等症。肺虚又要耗夺母气的自养,则病及于脾,脾虚气弱,而见气短,乏力、纳少、便溏等症.总之,本病始多为阴液亏损,病在于肺,继则阴虚火旺,肺肾同病或气阴两虚,肺脾同病。
发明内容
本发明的目的在于提供一种具有润肺补肾、活血滋补、益气滋阴、生津止渴的功效,用于肺虚干咳、虚劳咳嗽等症疗效确切。
本发明的技术方案:
为达到减轻疼痛、缓解症状的功效,本发明选择:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份、黄酒3000份;进行组合的,以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相、须、相使作用显著,具有提高免疫力作用,从而能够有效用于顳下颌关节功能紊乱综合征等症。
本发明选取的原料中药材中,其功效和药理作用分别是:
冬虫夏草:【化学成份】含水分10.84%,脂肪8.4%,粗蛋白25.32%,粗纤维18.53%,碳水化物28.90%,灰分4.10%。脂肪含饱和脂肪酸13.00%,不饱和脂肪酸82.2%。此外,还含虫草酸约7%,是奎宁酸的异构物。又含冬虫夏草素,是一种淡黄色结晶粉末,在试管内能抑制链球菌、鼻疽杆菌、炭疽杆菌、猪出血性败血症杆菌及葡萄状球菌的生长。另含维生素B120.29微克/100克。【功能主治】补虚损,益精气,止咳化痰。治痰饮喘嗽,虚喘,痨嗽,咯血,自汗盗汗,阳痿遗精,腰膝酸痛,病后久虚不复。
西洋参:【性味归经】甘、微苦,凉。归心、肺、肾经。【功能主治】补气养阴,清热生津。用于气虚阴亏,内热,咳喘痰血,虚热烦倦,消渴,口燥咽干。西洋参有抗疲劳、抗氧化、抗应激、抑制血小板聚集、降低血液凝固性的作用,另外,对糖尿病患者还有调节血糖的作用。
川贝母:清热润肺,化痰止咳。用于肺热燥咳,干咳少痰,阴虚劳嗽,咯痰带血。【性味归经】苦、甘,微寒。归肺、心经。【功能主治】清热润肺,化痰止咳。用于肺热燥咳,干咳少痰,阴虚劳嗽,咯痰带血。治虚劳咳嗽、吐痰咯血、心胸郁结、肺痿、肺痈、喉痹、乳痈。
麦冬:【药物性状】该品呈纺锤形,两端略尖,长1.5~3cm,直径0.3~0.6cm。表面黄白色或淡黄色,有细纵纹。质柔韧,断面黄白色,半透明,中柱细小。气微香,味甘、微苦。【性味归经】甘,微苦,微寒。归心、肺、胃经。【功能与主治】养阴生津,润肺清心。用于肺燥干咳,阴虚痨嗽,喉痹咽痛,津伤口渴,内热消渴,心烦失眠,肠燥便秘。【药物功效】1.养阴清热治疗阴虚内热或热病病伤津、心烦口渴。2.润肺止咳治疗燥热伤肺所致的咳嗽、痰稠、气逆。
夏枯草:【性味归经】:寒;苦、辛;归肝、胆经。【功能主治】:清火,明目,散结,消肿。用于目赤肿痛,目珠夜痛,头痛眩晕,瘰疬,瘿瘤,肿痛;甲状腺肿大,淋巴结结核,乳腺增生,高血压、高血糖、高血脂和高血粘。
百合:拣去杂质、黑瓣,簸除灰屑。性味:甘;微苦;微寒。归经:心;肺经。功能主治:养阴润肺;清心安神。主阴虚久嗽;痰中带血;热病后期;余热未清,或情志不遂所致的虚烦惊悸、失眠多梦、精神恍惚;痈肿;湿疮。
生地:具有止血、抗凝血、抗真菌作用,调节内分泌,并能促进肾上腺皮质激素的合成。性味归经:甘,寒。归心,肝,肾经。功能主治:具有清热凉血功效用于温热病热入营血,壮热神昏,口干舌绛。治温病后期,余热未尽,阴液已伤,夜热早凉,舌红脉数者。可用于治温热病热入营血,血热毒盛,吐血衄血,斑疹紫黑。用于津伤口渴,内热消渴。治温病伤阴,肠燥便秘。
党参:具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。性味归经:性平,味甘、微酸。归脾、肺经。
鳖甲:[性味]咸、寒。[功用]滋肾潜阳,软坚散结。[主治]骨蒸劳热、疟母、胁下坚硬、腰痛,经闭症瘕等症。
怀山药:具有营养滋补、诱生搅扰素、增强机体免疫力、调度内排泄、补气通脉、镇咳祛痰、平喘等感化,能改善冠状动脉及微轮回血流,可治疗慢性气管炎、冠芥蒂、心绞痛等。铁棍山药具有补气润肺的功用,既可切片煎汁当茶饮,又可切细煮粥喝,对虚性咳嗽及肺痨发烧患者都有很好的治疗结果。
大枣:味甘性温、归脾胃经,有补中益气、养血安神、缓和药性的功能;而现代的药理学则发现,红枣含有蛋白质、脂肪、醣类、有机酸、维生素A、维生素C、微量钙多种氨基酸等丰富的营养成份。枣能提高人体免疫力,并可抑制癌细胞:药理研究发现,红枣能促进白细胞的生成,降低血清胆固醇,提高血清白蛋白,保护肝脏,红枣中还含有抑制癌细胞,甚至可使癌细胞向正常细胞转化的物质。
天门冬:性寒,味甘,微苦。具有养阴清热,润肺滋肾的功效。用于治阴虚发热、咳嗽吐血、肺痈、咽喉肿痛、消渴、便秘等病症。天门冬含天门冬素、B-固甾醇、甾体皂甙,粘液质、糠醛衍生物等成分。实验证明,天门冬有升高血细胞、增强网状内皮系统舌噬功能和延长抗体存在时间的作用。
黄酒:含有丰富氨基酸;易于消化;舒筋活血;美容抗衰老;促进食欲;保护心脏;理想的药引子:相比于白酒、啤酒,黄酒酒精度适中,是较为理想的药引子。
本发明所述冬虫夏草中药酒,其原料药材分别是:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份、黄酒3000份;
其制备方法;制备方法为以下步骤:步骤一)称取原料药材:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份;共研成细末,过筛混匀,装入布袋,备用;
步骤二、将步骤一)所获得的原料药材入砂锅、加清水1升用小火煎煮至半。
步骤三、将步骤二)加入黄酒继续煮沸后放冷。密封。
步骤四、将步骤三)所获得的药酒浸泡7日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有提高免疫力作用。在治疗上能达到润肺补肾、活血滋补、益气滋阴、生津止渴的功效,用于肺虚干咳、虚劳咳嗽等症疗效确切。临床应用时具有良好的效果。本发明中药酒的功效在临床应用当中得到了证实,基本资料如:2006-2012,门诊临床应用本发明所述中药酒对674例体验者用;平均年龄42岁;服用方法:口服。每日早晚饭后饮用40-50ml;连续服用35-45日后,有效或显效519例;有效或显效的评价标准为:症状有所改善或者症状消失。
具体实施方法
本发明所述冬虫夏草中药酒,其原料药材分别是:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份、黄酒3000份;
其制备方法;制备方法为以下步骤:步骤一)称取原料药材:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份;共研成细末,过筛混匀,装入布袋,备用;
步骤二、将步骤一)所获得的原料药材入砂锅、加清水1升用小火煎煮至半;
步骤三、将步骤二)加入黄酒继续煮沸后放冷,密封;
步骤四、将步骤三)所获得的药酒浸泡7日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
Claims (2)
1.一种冬虫夏草中药酒,其特征在于:所选原料药材分别是:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份、黄酒3000份。
2.根据权利要求1所述的冬虫夏草中药酒,其特征在于制备方法:其制备方法为以下步骤:步骤一)称取原料药材:制备方法为以下步骤:步骤一)称取原料药材:冬虫夏草35份、西洋参18份、川贝母35份、麦冬26份、夏枯草32份、百合45份、生地35份、党参60份、鳖甲30份、怀山药45份、大枣70份、天门冬42份;共研成细末,过筛混匀,装入布袋,备用;
步骤二、将步骤一)所获得的原料药材入砂锅、加清水1升用小火煎煮至半;
步骤三、将步骤二)加入黄酒继续煮沸后放冷,密封;
步骤四、将步骤三)所获得的药酒浸泡7日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510909666.3A CN105412563A (zh) | 2015-12-06 | 2015-12-06 | 冬虫夏草中药酒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510909666.3A CN105412563A (zh) | 2015-12-06 | 2015-12-06 | 冬虫夏草中药酒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105412563A true CN105412563A (zh) | 2016-03-23 |
Family
ID=55491410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510909666.3A Pending CN105412563A (zh) | 2015-12-06 | 2015-12-06 | 冬虫夏草中药酒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105412563A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106085703A (zh) * | 2016-06-21 | 2016-11-09 | 王子田 | 一种明目山药黄酒及其制备方法 |
CN106434222A (zh) * | 2016-11-30 | 2017-02-22 | 都安瑶族自治县技术开发中心 | 一种具有润肺效果的保健酒 |
CN106520434A (zh) * | 2016-10-25 | 2017-03-22 | 青海珠峰冬虫夏草工程技术研究有限公司 | 一种冬虫夏草水果酒的生产方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417075A (zh) * | 2008-12-08 | 2009-04-29 | 贺立人 | 一种治疗呼吸系统疾病的中药 |
CN103768468A (zh) * | 2012-10-24 | 2014-05-07 | 彭卫斌 | 一种治疗肺结核的中药药物 |
CN104162076A (zh) * | 2014-07-23 | 2014-11-26 | 周剑峰 | 治疗肺结核的中药制剂 |
-
2015
- 2015-12-06 CN CN201510909666.3A patent/CN105412563A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417075A (zh) * | 2008-12-08 | 2009-04-29 | 贺立人 | 一种治疗呼吸系统疾病的中药 |
CN103768468A (zh) * | 2012-10-24 | 2014-05-07 | 彭卫斌 | 一种治疗肺结核的中药药物 |
CN104162076A (zh) * | 2014-07-23 | 2014-11-26 | 周剑峰 | 治疗肺结核的中药制剂 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106085703A (zh) * | 2016-06-21 | 2016-11-09 | 王子田 | 一种明目山药黄酒及其制备方法 |
CN106520434A (zh) * | 2016-10-25 | 2017-03-22 | 青海珠峰冬虫夏草工程技术研究有限公司 | 一种冬虫夏草水果酒的生产方法 |
CN106434222A (zh) * | 2016-11-30 | 2017-02-22 | 都安瑶族自治县技术开发中心 | 一种具有润肺效果的保健酒 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107213451A (zh) | 改善人体微循环障碍的益生菌发酵中药制剂及其制备方法 | |
CN102579708A (zh) | 一种壮阳补肾健肝肺的中药配方 | |
CN105412563A (zh) | 冬虫夏草中药酒 | |
CN105878574B (zh) | 一种治疗肾虚的中药组合物及其制备方法 | |
CN107184857A (zh) | 一种用于改善睡眠的保健品 | |
CN105920269A (zh) | 一种女性保健药酒 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN101249255A (zh) | 一种治疗小儿咳嗽的中成药及其制备方法 | |
CN101658316B (zh) | 一种增强免疫力、调节血脂、清咽利喉的饮料 | |
CN103417896A (zh) | 一种戒毒茶及其制备方法 | |
CN101669995A (zh) | 一种用于心脑血管疾病治疗和保健的组合物及其制备方法 | |
KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
CN106177437B (zh) | 一种改善女性阳虚体寒的玛咖组合物 | |
CN105031302A (zh) | 一种辅助治疗艾滋病免疫功能重建不全的中药组合物 | |
CN104687137A (zh) | 一种鹿茸健脑安神汤料的配方及生产方法 | |
CN108042744A (zh) | 一种用于治疗前列腺疾病的中药组合物及制备方法 | |
CN102988747A (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN103845460A (zh) | 治疗遗尿的中药组合物 | |
JP2000236835A (ja) | 紅豆杉を主原料とした食品及びその製造法 | |
CN103169853B (zh) | 一种治疗肾阴虚型再生障碍性贫血的中药组合物 | |
CN107007748A (zh) | 改善体虚症状的中药组合物、药物及其制备方法和应用 | |
CN105770081A (zh) | 用于促进脑出血手术后愈合的组合物制剂及其制备方法 | |
CN104784587A (zh) | 一种治疗内分泌失调型不孕的中药组合物及其制备方法 | |
CN105012732A (zh) | 一种用于治疗睡眠障碍综合征的中药丸剂及制备方法 | |
CN105106600A (zh) | 一种促进因车祸致脑部外伤手术后愈合的组合物及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160323 |